STAAR Surgical Company
STAAR Surgical designs, develops, manufactures, and markets implantable lenses for the eye and companion delivery systems. The company provides ICLs to treat visual disorders such as myopia, hyperopia, astigmatism, and presbyopia. Products are marketed to healthcare providers, including ophthalmic surgeons, vision centers, hospitals, and distributors. The company sells products directly in several countries and through independent distributors internationally. Founded in 1982, STAAR Surgical is headquartered in Lake Forest, California.
Overview
Sector
Medical Instruments & Supplies
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- With a depreciation Potential of -94.42%, based on our fundamental analysis, it suggests the stock may be overvalued.
- The company has high debt. Net Debt to EBITDA Ratio (51.55) is higher than the sector mean.
- The company have lower returns than the sector in which it operates. ROIC (3.61%) is significantly lower than the sector mean (8.23%).
- EV/EBITDA (100.00) is significantly higher than the sector mean (47.53).
- EV/EBIT (100.00) is significantly higher than the sector mean.
- The Price to Free Cash Flow ratio (100.00) is significantly higher than the sector mean.
- EBITDA Margin (0.00%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | 3.6% |
| Net Debt/EBITDA | 51.5 |